Alzheimer's and Parkinson's charities identify new ways to reuse current drugs

Experts say that by repurposing drugs, they can 'increase the shots on target' at tackling the diseases.
This method of drug development could also reduce the time patients are left waiting for new treatments by up to 10 years, they added.
It comes after the NHS spending watchdog rejected the use of new Alzheimer's drugs lecanemab and donanemab for widespread use in the health service.
The drugs were approved for use in the UK last year by the UK's medicines regulator but the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), said they could not be used in the NHS because the benefits are 'too small' to justify the cost.
Now charities Cure Parkinson's and Alzheimer's Research UK have joined forces to find current drugs that may tackle some of the common biology behind both diseases.
https://x.com/AlzResearchUK/status/1929856926885539966/photo/2
After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson's over a decade ago, experts from both fields will select the most promising drugs for both Parkinson's and dementia, so they can be moved quickly into clinical trials.
Weight loss jabs are already being investigated for their effectiveness in treating symptoms of both diseases and experts hope to uncover more drugs that can have multiple uses.
Semaglutide, the active ingredient for weight loss and diabetes drugs Wegovy and Ozempic, is being examined in clinical trials to see whether it can help patients with Alzheimer's disease or Parkinson's.
Trial results for the Alzheimer's trial are expected to be published later this year.
Dr Sheona Scales, director of research at Alzheimer's Research UK, told the PA news agency that the iLCT project had already been 'hugely successful' with people who have Parkinson's, adding: 'Around 30% of disease modifying therapies that are in clinical trials for Parkinson's disease came through this process.
'What we wanted to do is to build on their knowledge and experience and expertise in order to be able to bring a process similar to that to Alzheimer's disease.'
Dr Scales said that there are some 'common grounds' between Parkinson's and Alzheimer's – both are neurodegenerative diseases and have some 'common biological processes' – such as inflammation, mitochondrial dysfunction and 'protein misfolding' – which could be targets for repurposed drugs.
'Getting multiple drugs that are targeting the disease is really important to us,' she said.
'Testing different types of drugs and getting as many shots on target is important.'
She said: 'Repurposed drugs have already been demonstrated to be safe for use in humans development of new drugs for different diseases is a long process.
'What essentially bringing repurposed drugs does, is help to accelerate the drug development pipeline – it could save between five and 10 years within that process, compared to taking a new drug through clinical trials for the very first time.'
Helen Matthews, chief executive of Cure Parkinson's, said the iLCT was originally set up to identify drugs that can potentially 'slow down, stop or reverse Parkinson's'.
She added: 'It was through this programme that we realised that there were so many drugs that were also being looked at in the dementia field and there were commonalities there in terms of the drugs looking to reduce inflammation, or whatever it might be, there were specific pathways that those drugs were working on that could be beneficial for both disease areas.
'So given that we were already doing the (work) every year, it made sense to join forces in this way, just to add efficiencies.
'Because if you're looking at the same drugs, we'll only do that digging once, you know, only do that compilation of the dossiers once, so that you can actually take the learning for both diseases and then actually look and see which might be beneficial.'
She said that the 'sharing of knowledge and digging' could also be shared with other disease areas, such as MS.
And on lecanemab and donanemab, Dr Scales added: '(These) were the first disease-targeting therapies that have been licensed in the UK, but obviously are not available on the NHS at the moment.
'They showed for the very first time that we were able to alter the course of the disease.
'And what we're looking forward to now is what the next generation of treatments can bring us and how we can target different parts of the disease.'
Dr Lucy Devendra, head of research at Alzheimer's Society, said: 'Repurposing medicines which are already known to be safe can help us find new treatments for the diseases that cause dementia much quicker.
'Although it is still early days, it's encouraging to see a renewed focus on this type of research and development.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Scottish Sun

34 minutes ago

• Scottish Sun

The strange sign in your EARWAX that can predict if you'll develop devastating brain disorder

Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) YOUR earwax could be used to predict whether you'll develop Parkinson's, scientists say, About 153,000 people in the UK live with the devastating neurological disorder, caused by a loss of nerve cells in the brain. Sign up for Scottish Sun newsletter Sign up 2 Earwax could be used to predict whether someone will get Parkinson's or catch the disease in its early stages Credit: Getty The progressive disease is characterised by symptoms such as tremors, slow movement and muscle stiffness, which slowly get worse. According to researchers Zhejiang University in China, most Parkinson's treatments only slow the disease's progression, so early diagnosis is important for managing symptoms. But current tests for spotting the disease - such as brain scans or rating scales - can be expensive or subjective, they said. Now, a study published to Analytical Chemistry suggests that earwax could be used as a cost effective way to screen people for Parkinson's. Researchers claimed they'd developed a new AI system that could help catch the disease at an early stage, using earwax samples. Previous studies have shown that changes in sebum - an oily substance secreted by the skin - could help identify people with Parkinson's. Sebum from people with the disease may have a characteristic, musky smell because volatile organic compounds released by sebum are altered by disease progression. But sebum on the surface of the skin isn't a reliable substance for testing as it's exposed to pollution or humidity, which can change its composition. However, sebum in ear canals is sheltered from the elements. Seeing as the oily substance is the main component of earwax and it's easy to sample, researchers decided to use it for their screening tool. Good Morning Britain star reveals Parkinson's diagnosis after tragic death of his wife To identify the compounds released by sebum in people with Parkinson's, the researchers swabbed the ear canals of 209 participants, more than half of which were diagnosed with the condition. They then analysed wax samples, identifying four volatile organic compounds specific to people with Parkinson's. Those include ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. Researchers said these could serve as potential biomarkers for Parkinson's. Using these findings, they were able to develop a system that inexpensively screens for Parkinson's. Everything you need to know about Parkinson's Parkinson's is a progressive neurological condition, meaning that it causes problems in the brain and gets worse over time. It affects around 153,000 people in the UK. People with Parkinson's don't have enough of the chemical dopamine because some of the nerve cells that make it have stopped working. This can cause a range of more than 40 symptoms, but the three main ones are: Tremor (shaking) Slow movement Rigidity (muscle stiffness) Other common signs include: Mild memory and thinking problems Trouble sleeping Issues with balance Pain Anxiety and depression Shuffling walk with very small steps Difficulty making facial expressions Loss of sense of smell Problems peeing Constipation The four main ways of managing Parkinson's include medication, staying active, exploring occupational therapy, physical therapy and speech and language therapy, and monitoring symptoms. Source: Parkinson's UK and NHS They trained an artificial intelligence olfactory system - a robotic model that can mimic how we smell - with their ear wax compound data. They found it was able to categorise samples with and without Parkinson's with 94 percent accuracy. Researchers suggested their system could be used to a first-line screening tool for early Parkinson's detection and could help improve care for condition by making it possible to administer treatments earlier. Author Hao Dong said: 'This method is a small-scale single-center experiment in China." 2 'The next step is to conduct further research at different stages of the disease, in multiple research centres and among multiple ethnic groups, in order to determine whether this method has greater practical application value.' Earlier this year, scientists warned of a surge in cases of Parkinson's. They said 25 million people across the world will be living with the debilitating brain condition by 2050. Researchers from Capital Medical University in Beijing, China, estimated that an ageing population would drive the surge in cases of Parkinson's disease over the next 25 years. According to Parkinson's UK, the condition is the fastest growing neurological condition in the world.

Daily Mirror

35 minutes ago

• Daily Mirror

Man drinks energy drink on way to work each day but realises he's made error

A woman shared the story of her husband's massive energy drink error, and many found it funny, sharing their stories of massive fails they'd experienced around soft drinks If you're feeling exhausted after a rubbish night's sleep, rather than reaching for a coffee, some people will opt for something a little bit stronger. Energy drinks are often packed full of caffeine, and while not particularly known for their health benefits, they certainly can make you feel more alert and 'with it' if you've got a big day ahead. The NHS recommends that you avoid excessive consumption of them due to their high caffeine and often sugar content, however. Some energy drinks contain three to seven times as much caffeine as a can of Coke, so if you drink them regularly, you may face health problems. ‌ But when one woman realised that her husband had been taking a daily 'energy drink' to work, she was left horrified, because it wasn't actually an energy drink he was drinking. ‌ She posted on X, writing: "I just found out my husband thought White Claws were energy drinks and he's been drinking one on the way to work every day". White Claw is a brand of hard seltzer, consisting of sparkling water, a gluten-free alcohol base (often derived from fermented sugars or grains), and a hint of natural fruit flavouring. They're a good option for those looking for a lower-calorie and carb substitute for other alcohols. The alcohol percentage of White Claw Hard Seltzer is 4.5% ABV. This applies to their standard flavours like Black Cherry, Raspberry, Natural Lime, and Mango. They have a 'surge' variety, too, however, that is 8% ABV - and it's not clear which one the man was allegedly drinking before he went to work. ‌ " Red Bull gives you wings, but White Claw will give you a DUI (driving under the influence)," somebody joked. Another said that the post made them "laugh out loud so f****** hard" because they couldn't believe he'd been accidentally drinking alcohol. Someone shared a similar experience of their son helping himself to some of her sake with a meal. ‌ She wrote: "I was at a Japanese restaurant when my son was six, and he tried the hot mustard, panicked from the heat, and grabbed my sake, and slammed it. It happened so fast that there was no stopping it". Another said that there's no problem with being introduced to alcohol at a young age, however, saying: "I was raised in a Sicilian family. "We were served Chianti/wine starting at 6 years old, always given a little bit with dinner with the rest of the family. I never developed a taste for alcohol. I've never been drunk. I rarely drink except wine with dinner". ‌ One dad shared his horror when he accidentally gave his young daughter wine to take to school, penning: "I was a stay-at-home dad for a little bit while my daughters were in middle school. I packed their lunches daily. "One day, I was out of juice and grabbed a drink can and put it in a lunchbox. Only after school did I realise I gave her a wine cooler. She said it tasted funny". Others in the thread said they "didn't believe" it, asking why he'd show ID for an energy drink when he bought them. Some just said that the "thread is so funny" with people sharing their own fails, encouraging people to post more stories.

Wales Online

39 minutes ago

• Wales Online

Jourdan Dunn donates blood and calls for more black heritage donors

Jourdan Dunn donates blood and calls for more black heritage donors Dunn, known for appearing on the catwalks of London, Paris and New York, attended the capital's newest blood donation centre in Brixton, south London, to mark World Sickle Cell Day. Jourdan Dunn (Image: Charlotte Tilbury ) Model Jourdan Dunn has highlighted the need for more black heritage donors to come forward to give blood – as she provided a blood donation herself. Dunn, known for appearing on the catwalks of London, Paris and New York, attended the capital's newest blood donation centre in Brixton, south London, to mark World Sickle Cell Day. ‌ Dunn's teenage son Riley is one of the country's 13,000 sickle cell patients who rely on blood transfusions from black heritage donors so they can live with the condition. ‌ Sickle cell is the country's fastest-growing inherited blood disorder that disproportionately affects black African and black Caribbean communities, according to the NHS. Around 250 babies are born with the condition in the UK each year. The service currently needs to recruit 16,000 new black heritage blood donors this year to meet the growing need. Article continues below Regular blood transfusions form the first line of defence against the condition, with patients responding best to donations containing the Ro blood type, which is significantly more prevalent in donors of black heritage. More than half (56%) of donors of black heritage are likely to have the Ro blood type, compared with just 2.4% of other ethnicities. Dunn, 34, said: "As a mother who has seen her child battle sickle cell, I am committed to doing all I can to help him, and the thousands of other people with the condition, have the best chance to live a full and healthy life. ‌ "That's why I've come to Brixton to give blood and ask the black community to register to do the same. "By giving an hour of your time three to four times a year, you can save up to 12 lives – that's an amazing power you have in your hands. "I'm incredibly thankful to the record numbers of black donors who have given blood in Brixton and across the country, but as numbers of sickle cell patients increase, so too does the need for more donors to come forward. ‌ NHS Blood and Transplant (NHSBT) director of donor experience Mark Chambers said: "We've seen a great response to our calls for more black heritage donors to sign up to become blood donors, but the need for more to register and become regular blood donors is growing. "Blood transfusions to pre-empt sickle cell crises are helping more people live well with the condition, but on average we need 250 donations a year to help them, that's why it's vitally important we recruit more black heritage donors. "Jourdan's support, both as an NHS ambassador and a donor, will hopefully encourage others to follow her lead and spare an hour of their time to make a lifesaving difference." ‌ Sickle cell patient Calvin Campbell said: "I owe my life to the generosity of black heritage donors. "Every four weeks I need to have 10 to 12 units of blood transfused into my body to allow me to be relatively healthy. "Without those blood donations I would have died years ago and not have the life I have now. Article continues below "I wouldn't have had children, grandchildren, and the ability to work." Those wanting to donate blood can register via the NHSBT app, visit or call 0300 123 23 23.